AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Silo Pharma, Inc. (SILO) has recently announced that Director and Chief Executive Officer, Weisblum Eric, has executed two transactions involving the purchase of shares of the company's common stock. On November 21, 2025, Mr. Weisblum acquired 1000 shares at a price of $0.37 per share. Similarly, on November 20, 2025, he also purchased 1000 shares at the same price.
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet